Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
50 /100
MEDIUM RISK
Score updated Oct 13, 2026

DMII — Drugs Made In America Acquisition II Corp. Dilution Risk Tracker

Track DMII dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track DMII — Get alerts when the score changes →

As of October 13, 2026, Drugs Made In America Acquisition II Corp. (DMII) has a DilutionWatch DilutionScore of 50/100, rated MEDIUM dilution risk. Drugs Made In America Acquisition II Corp. has a market capitalization of $649.10M, 63.70M shares outstanding, 68 institutional holders tracked.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
40
💰 Cash Runway
85
📊 Float Risk
17
⚠️ Warrant Exposure
40
🔄 Convertible Debt
40

Dilution Forecast

⛅
Watch
Minor dilution signals detected
model est. 17%
💰 Capital Raise model 35%
• Low cash runway: 4 months remaining
🔔 Track DMII — Get forecast alerts →

Market Data

Market Cap$649.10M
Shares Outstanding63.70M
Float50.26M
Cash$175.0K
Debt$450.0K
Short InterestN/A

Source-Backed Evidence Depth

This public preview uses stored DilutionWatch fields and linked SEC/market records only. Missing values are not estimated.

FieldCurrent ValueBasis
DilutionScore50/100DilutionWatch score record
Shares Outstanding63.70MVerified float table or market cache
Public Float50.26MVerified float table or market cache
Market Cap$649.10MMarket data cache
Cash Runway3.8 monthsDilutionWatch score inputs
Shelf CapacityNone in current score inputsSEC-derived dilution fields
ATM CapacityNone in current score inputsSEC-derived dilution fields
Outstanding WarrantsNone in current score inputsSEC-derived dilution fields

Recent source-backed SEC insight records available on this page: 3.

Recent SEC source mix: 8-K 3.

The page does not infer future share issuance, financing probability, cash needs, management intent, or price impact when source fields are absent.

Institutional Holdings

QoQ: ↑ 26.2% shares (2026Q1 vs prior)
68 institutional holders · 44.25M shares
#1 MMCAP International Inc. SPC 2.70M shares
#2 Magnetar Financial LLC 2.70M shares
#3 Karpus Management, Inc. 2.60M shares
+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest121.5K
Days to Cover2.1
% of Float0.2%
FINRA data as of Sep 30, 2026

Recent SEC Activity

8-K 8K EVENT 2026-04-28
8-K 8K EVENT 2026-04-03
8-K 8K EVENT 2026-03-17
Full SEC filing analysis available with free account →

Recent News

No recent news available for this ticker.

Factual DMII Dilution Snapshot

Drugs Made In America Acquisition II Corp. (DMII) has a DilutionScore of 50/100, rated Medium dilution risk. Score date: October 13, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

DilutionScore History — Last 90 Days

DMII's DilutionScore is currently 50/100 (Medium risk), with 2 score changes tracked over 89 days. The score deteriorated from 65/100 (High risk).

Period Score Risk Level Duration
Oct 13, 202650/100MEDIUM1 day
Aug 22 – Oct 12, 202665/100HIGH52 days
Jul 16 – Aug 21, 202658/100HIGH36 days

Score recalculated daily from SEC filings and market data. Sign up free for real-time score change alerts.

Track DMII Dilution Risk in Real-Time
DilutionWatch monitors SEC filings 24/7 and alerts you the moment DMII files a shelf registration, ATM offering, warrant notice, or convertible note. Free tier available — no credit card required.
Start Tracking DMII — Free
Email alert within minutes of any SEC filing Daily DilutionScore™ recalculation Score history & trend tracking Tracks 8,000+ tickers simultaneously

Related Stocks — MEDIUM Risk

Other MEDIUM dilution risk stocks tracked by DilutionWatch with similar profiles:

Browse all 8,490+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for DMII
DMII FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.